Keywords
Last Name
Institution

Kari E. Reuter Roberts

TitleAssociate Professor
InstitutionTufts Medical Center
DepartmentMedicine
AddressPulmonary and Critical Care
Tufts Medical Center
800 Washington Street, Box 257
Boston MA 02111
Phone(617) 636-5513
Fax(617) 636-5953
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Al-Naamani N, Preston IR, Hill NS, Roberts KE. The prognostic significance of pulmonary arterial capacitance in pulmonary arterial hypertension: single-center experience. Pulm Circ. 2016 Dec; 6(4):608-610. PMID: 28090304.
      View in: PubMed
    2. Al-Naamani N, Sagliani KD, Dolnikowski GG, Warburton RR, Toksoz D, Kayyali U, Hill NS, Fanburg BL, Roberts KE, Preston IR. Plasma 12- and 15-hydroxyeicosanoids are predictors of survival in pulmonary arterial hypertension. Pulm Circ. 2016 Jun; 6(2):224-33. PMID: 27252849.
      View in: PubMed
    3. Preston IR, Roberts KE, Miller DP, Sen GP, Selej M, Benton WW, Hill NS, Farber HW. Response to Letter Regarding Article, "Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)". Circulation. 2016 May 17; 133(20):e662. PMID: 27185031.
      View in: PubMed
    4. Al-Naamani N, Palevsky HI, Lederer DJ, Horn EM, Mathai SC, Roberts KE, Tracy RP, Hassoun PM, Girgis RE, Shimbo D, Post WS, Kawut SM. Prognostic Significance of Biomarkers in Pulmonary Arterial Hypertension. Ann Am Thorac Soc. 2016 Jan; 13(1):25-30. PMID: 26501464.
      View in: PubMed
    5. Preston IR, Roberts KE, Miller DP, Sen GP, Selej M, Benton WW, Hill NS, Farber HW. Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL). Circulation. 2015 Dec 22; 132(25):2403-11. PMID: 26510696.
      View in: PubMed
    6. Al-Naamani N, Preston IR, Paulus JK, Hill NS, Roberts KE. Reply: The Diastolic Pressure Gradient Does Not-and Should Not-Predict Outcomes. JACC Heart Fail. 2015 Oct; 3(10):846. PMID: 26450005.
      View in: PubMed
    7. Al-Naamani N, Preston IR, Paulus JK, Hill NS, Roberts KE. Pulmonary Arterial Capacitance Is an Important Predictor of Mortality in Heart Failure With a Preserved Ejection Fraction. JACC Heart Fail. 2015 Jun; 3(6):467-74. PMID: 26046840.
      View in: PubMed
    8. Hill NS, Preston IR, Roberts KE. Inhaled Therapies for Pulmonary Hypertension. Respir Care. 2015 Jun; 60(6):794-805. PMID: 26070575.
      View in: PubMed
    9. Matura LA, Ventetuolo CE, Palevsky HI, Lederer DJ, Horn EM, Mathai SC, Pinder D, Archer-Chicko C, Bagiella E, Roberts KE, Tracy RP, Hassoun PM, Girgis RE, Kawut SM. Interleukin-6 and Tumor Necrosis Factor-a Are Associated with Quality of Life-Related Symptoms in Pulmonary Arterial Hypertension. Ann Am Thorac Soc. 2015 Mar; 12(3):370-5. PMID: 25615959.
      View in: PubMed
    10. Al-Naamani N, Roberts KE, Hill NS, Preston IR. Imatinib as rescue therapy in a patient with pulmonary hypertension associated with Gaucher disease. Chest. 2014 Sep; 146(3):e81-3. PMID: 25180747.
      View in: PubMed
    11. Al-Naamani N, Roberts KE. Portopulmonary hypertension. Clin Chest Med. 2013 Dec; 34(4):719-37. PMID: 24267301.
      View in: PubMed
    12. Sadoughi A, Roberts KE, Preston IR, Lai GP, McCollister DH, Farber HW, Hill NS. Use of selective serotonin reuptake inhibitors and outcomes in pulmonary arterial hypertension. Chest. 2013 Aug; 144(2):531-41. PMID: 23558791.
      View in: PubMed
    13. Paulus JK, Roberts KE. Oestrogen and the sexual dimorphism of pulmonary arterial hypertension: a translational challenge. Eur Respir J. 2013 May; 41(5):1014-6. PMID: 23633611.
      View in: PubMed
    14. Preston IR, Sagliani KD, Roberts KE, Shah AM, Desouza SA, Howard W, Brennan J, Hill NS. Comparison of acute hemodynamic effects of inhaled nitric oxide and inhaled epoprostenol in patients with pulmonary hypertension. Pulm Circ. 2013 Jan; 3(1):68-73. PMID: 23662176; PMCID: PMC3641742.
      View in: PubMed
      View in: PubMed Central
    15. Wei L, Warburton RR, Preston IR, Roberts KE, Comhair SA, Erzurum SC, Hill NS, Fanburg BL. Serotonylated fibronectin is elevated in pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2012 Jun 15; 302(12):L1273-9. PMID: 22523280; PMCID: PMC3379044.
      View in: PubMed
      View in: PubMed Central
    16. Kawut SM, Bagiella E, Lederer DJ, Shimbo D, Horn EM, Roberts KE, Hill NS, Barr RG, Rosenzweig EB, Post W, Tracy RP, Palevsky HI, Hassoun PM, Girgis RE. Randomized clinical trial of aspirin and simvastatin for pulmonary arterial hypertension: ASA-STAT. Circulation. 2011 Jun 28; 123(25):2985-93. PMID: 21593252; NIHMSID: NIHMS297051.
      View in: PubMed
    17. Kawut SM, Bagiella E, Shimbo D, Lederer DJ, Al-Naamani N, Roberts KE, Barr RG, Post W, Horn EM, Tracy R, Hassoun P, Girgis R. Rationale and design of a phase II clinical trial of aspirin and simvastatin for the treatment of pulmonary arterial hypertension: ASA-STAT. Contemp Clin Trials. 2011 Mar; 32(2):280-7. PMID: 21146637; NIHMSID: NIHMS265000.
      View in: PubMed
    18. Roberts KE, Kawut SM, Krowka MJ, Brown RS, Trotter JF, Shah V, Peter I, Tighiouart H, Mitra N, Handorf E, Knowles JA, Zacks S, Fallon MB. Genetic risk factors for hepatopulmonary syndrome in patients with advanced liver disease. Gastroenterology. 2010 Jul; 139(1):130-9.e24. PMID: 20346360; NIHMSID: NIHMS212630.
      View in: PubMed
    19. Tanikella R, Kawut SM, Brown RS, Krowka MJ, Reinen J, Dinasarapu CR, Trotter JF, Roberts KE, Mohd MA, Arnett DK, Fallon MB. Health-related quality of life and survival in liver transplant candidates. Liver Transpl. 2010 Feb; 16(2):238-45. PMID: 20104497; NIHMSID: NIHMS212627.
      View in: PubMed
    20. Roberts KE, Preston IR. Safety and tolerability of bosentan in the management of pulmonary arterial hypertension. Drug Des Devel Ther. 2009; 3:111-8. PMID: 19920927; PMCID: PMC2769225.
      View in: PubMed
      View in: PubMed Central
    21. Peng T, Zamanian R, Krowka MJ, Benza RL, Roberts KE, Taichman DB, Rybak D, Trotter JF, Brown RS, Fallon MB, Kawut SM. Plasma levels of S100A4 in portopulmonary hypertension. Biomarkers. 2009 May; 14(3):156-60. PMID: 19399660; NIHMSID: NIHMS90534.
      View in: PubMed
    22. Roberts KE, Fallon MB, Krowka MJ, Brown RS, Trotter JF, Peter I, Tighiouart H, Knowles JA, Rabinowitz D, Benza RL, Badesch DB, Taichman DB, Horn EM, Zacks S, Kaplowitz N, Kawut SM. Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease. Am J Respir Crit Care Med. 2009 May 1; 179(9):835-42. PMID: 19218192; PMCID: PMC2675568.
      View in: PubMed
      View in: PubMed Central
    23. Roberts KE, Fallon MB, Krowka MJ, Benza RL, Knowles JA, Badesch DB, Brown RS, Taichman DB, Trotter J, Zacks S, Horn EM, Kawut SM. Serotonin transporter polymorphisms in patients with portopulmonary hypertension. Chest. 2009 Jun; 135(6):1470-5. PMID: 19141529; PMCID: PMC2716711.
      View in: PubMed
      View in: PubMed Central
    24. Hill NS, Preston IR, Roberts KE. Inoperable chronic thromboembolic pulmonary hypertension: treatable with medical therapy. Chest. 2008 Aug; 134(2):221-3. PMID: 18682450.
      View in: PubMed
    25. Hill NS, Preston IR, Roberts KE. Patients with pulmonary arterial hypertension in clinical trials: who are they? Proc Am Thorac Soc. 2008 Jul 15; 5(5):603-9. PMID: 18625752.
      View in: PubMed
    26. Kawut SM, Krowka MJ, Trotter JF, Roberts KE, Benza RL, Badesch DB, Taichman DB, Horn EM, Zacks S, Kaplowitz N, Brown RS, Fallon MB. Clinical risk factors for portopulmonary hypertension. Hepatology. 2008 Jul; 48(1):196-203. PMID: 18537192; NIHMSID: NIHMS173603.
      View in: PubMed
    27. Fallon MB, Krowka MJ, Brown RS, Trotter JF, Zacks S, Roberts KE, Shah VH, Kaplowitz N, Forman L, Wille K, Kawut SM. Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates. Gastroenterology. 2008 Oct; 135(4):1168-75. PMID: 18644373; NIHMSID: NIHMS112591.
      View in: PubMed
    28. Rosenzweig EB, Morse JH, Knowles JA, Chada KK, Khan AM, Roberts KE, McElroy JJ, Juskiw NK, Mallory NC, Rich S, Diamond B, Barst RJ. Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension. J Heart Lung Transplant. 2008 Jun; 27(6):668-74. PMID: 18503968.
      View in: PubMed
    29. Willers ED, Newman JH, Loyd JE, Robbins IM, Wheeler LA, Prince MA, Stanton KC, Cogan JA, Runo JR, Byrne D, Humbert M, Simonneau G, Sztrymf B, Morse JA, Knowles JA, Roberts KE, McElroy JJ, Barst RJ, Phillips JA. Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med. 2006 Apr 1; 173(7):798-802. PMID: 16339917; PMCID: PMC2662954.
      View in: PubMed
      View in: PubMed Central
    30. Roberts KE, Barst RJ, McElroy JJ, Widlitz A, Chada K, Knowles JA, Morse JH. Bone morphogenetic protein receptor 2 mutations in adults and children with idiopathic pulmonary arterial hypertension: association with thyroid disease. Chest. 2005 Dec; 128(6 Suppl):618S. PMID: 16373874.
      View in: PubMed
    31. Roberts KE, Hamele-Bena D, Saqi A, Stein CA, Cole RP. Pulmonary tumor embolism: a review of the literature. Am J Med. 2003 Aug 15; 115(3):228-32. PMID: 12935829.
      View in: PubMed
    Roberts's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _
    This website was supported by the National Center for Research Resources Award Number UL1RR025752 and the National Center for Advancing Translational Sciences, National Institutes of Health, Award Numbers UL1TR000073 and UL1TR001064. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

    Disclaimer | Tufts University | Tufts CTSI 2015